RSV vaccine being tested for pregnant women helps protect their newborns, new research shows
CBSN
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Pfizer announced Tuesday that a large international study found vaccinating moms-to-be was nearly 82% effective at preventing severe cases of RSV in their babies' most vulnerable first 90 days of life. At age 6 months, the vaccine still was proving 69% effective against serious illness - and there were no signs of safety problems in mothers or babies.
"Moms are always giving their antibodies to their baby," said virologist Kena Swanson, Pfizer's vice president of viral vaccines. "The vaccine just puts them in that much better position" to form and pass on RSV-fighting antibodies.
Washington — The Supreme Court on Friday said it will consider the constitutionality of the Federal Communications Commission's Universal Service Fund, agreeing to review a lower court decision that upended the mechanism for funding programs that provide communications services to rural areas, low-income communities and schools, libraries and hospitals.
Jeff Bezos' Blue Origin launched six space tourists on a high-speed dash to the edge of space and back Friday, giving the passengers — including a husband and wife making their second flight — about three minutes of weightlessness and an out-of-this world view before the capsule made a parachute descent to touchdown at the company's west Texas flight facility.